“It’s healthcare 2.0. This is going to change everything.” Kevin Kelly explains why now is a 2007 iPhone moment for many of the companies in his biotech-focused XDNA fund. Top holdings include Beam Therapeutics (BEAM), Intellia (NTLA), Editas Medicine (EDIT), Crispr Therapeutics (CRSP), Verve Therapeutics (VERV), and bluebird (BLUE). Kelly also weighs in on the hotel and lodging sector with the HOTL ETF. Top holdings include Vici Properties (VICI), Airbnb (ABNB), Hilton (HLT), Marriott (MAR), Hyatt (H), and Gaming & Leisure (GLPI).
15 Sep 2022
Market On Close
23 Jan 2023
Market On Close
14 Dec 2022
Morning Trade Live
14 Nov 2022
The Watch List
09 Dec 2022
The Watch List
31 Jan 2023
The Watch List
22 Jan 2023